Bradenton, FL4 Active Studies

Interstitial Cystitis Clinical Trials in Bradenton, FL

Find 4 actively recruiting interstitial cystitis clinical trials in Bradenton, FL. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
200,782
Enrolling

Recruiting Interstitial Cystitis Studies in Bradenton

About Interstitial Cystitis Clinical Trials in Bradenton

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 4 interstitial cystitis clinical trials recruiting participants in Bradenton, FL. These studies are seeking a combined 200,782 participants. Research is being sponsored by OMNI Medical Services, LLC, Pfizer, Pacira Pharmaceuticals, Inc and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Bradenton — FAQ

Are there interstitial cystitis clinical trials in Bradenton?

Yes, there are 4 interstitial cystitis clinical trials currently recruiting in Bradenton, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bradenton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bradenton research site will contact you about next steps.

Are clinical trials in Bradenton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bradenton studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 4 active trials in Bradenton are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated March 2, 2026 from ClinicalTrials.gov